Virus membrane fusion proteins: Biological machines that undergo a metamorphosis

Bioscience Reports

Volumn 20, Issue 6, 2000, Pages 597-612

  Ellis Dutch, R ^a   Jardetzky, T S ^b   Lamb, R A ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Fusion peptides; Glycosylation; Heptad repeats; Membrane fusion; Oligomerization; Proteolytic processing; Viral glycoprotein

Indexed keywords

VIRUS FUSION PROTEIN;

CELL FUSION; CELL SURFACE; NONHUMAN; PARAMYXOVIRUS; PROTEIN DEGRADATION; SHORT SURVEY; VIRUS CELL INTERACTION;

MEMBRANE FUSION; PROTEIN STRUCTURE, TERTIARY; VIRAL FUSION PROTEINS;

EBOLA VIRUS; INFLUENZA VIRUS; PARAMYXOVIRIDAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0034445297     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010467106305     Document Type: Short Survey

References (105)

1. Intracellular processing, glycosylation, and cell-surface expression of the measles virus fusion protein (F) encoded by a recombinant adenovirus
2. Functional analysis of N-linked glycosylation mutants of the measles virus fusion protein synthesized by recombinant vaccinia virus vectors
3. Why is a specific amino acid sequence of F glycoprotein required for the membrane fusion reaction between envelope of HVJ (Sendai virus) and target cell membranes?
4. Individual roles of N-linked oligosaccharide chains in intracellular transport of the paramyxovirus SV5 fusion protein
5. Structural basis for paramyxovirus-mediated membrane fusion
6. A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein
7. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion
8. Structure of influenza haemagglutinin at the pH of membrane fusion
9. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41
10. Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies
11. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein
12. A spring-loaded mechanism for the conformational change of influenza hemagglutinin
13. Cell fusion by the envelope glycoproteins of persistent measles viruses which cause lethal human brain disease
14. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins
15. Core structure of gp41 from the HIV envelope glycoprotein
16. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation
17. N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA2 subunit to form an N cap that terminates the triple-stranded coiled coil
18. Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein
19. Replication of influenza virus in a continuous cell line: High yield of infective virus from cells inoculated at high multiplicity
20. Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory synctial virus
21. Assembly of influenza hemagglutinin trimers and its role in intracellular transport
22. Receptor-triggered membrane association of a model retroviral glycoprotein
23. Quaternary structure of influenza virus hemagglutinin after acid treatment
24. Folding and assembly of viral membrane proteins
25. Paramyxovirus fusion protein: Characterization of the core trimer, a rod-shaped complex with helices in anti-parallel orientation
26. Paramyxovirus fusion (F) protein: A conformational change on cleavage activation
27. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein
28. The fusion and hemagglutinin-neurominidase glycoproteins of human parainfluenza virus 3 are both required for fusion
29. Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket
30. Retrovirus envelope domain at 1.7 Å resolution
31. Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin
32. The glycosylation of human immnodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160
33. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain
34. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements
35. Capture of an early fusion-active conformation of HIV-1 gp41
36. Glycosylation requirements for intracellular transport and function of the hemagglutinin of influenza virus
37. Expression of wild-type and mutant forms of influenza hemagglutinin: The role of folding in intracellular transport
38. Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120
39. A novel mechanism for the acquisition of virulence by a human influenza A virus
40. Virus-cell and cell-cell fusion
41. Activation of a retroviral membrane fusion protein: Soluble receptor-induced liposome binding of the ALSV envelope glycoprotein
42. Trypsin action on the growth of Sendai virus in tissue culture cells. I. Restoration of the infectivity for L cells by direct action of trypsin on L cell-borne Sendai virus
43. Trypsin action on the growth of Sendai virus in tissue culture cells. III. Structural differences of Sendai viruses grown in eggs and tissue culture cells
44. Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: Roles of conserved residues in cell fusion
45. Biological activity of paramyxovirus fashion proteins: Factors influencing formation of Syncytia
46. Activation of the Sendai virus fusion protein (F) involves a conformational change with exposure of a new hydrophobic region
47. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses
48. Retrovirus envelope glycoproteins
49. HIV-1 inhibition by a peptide
50. Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41
51. A core trimer of the paramyxovirus fusion protein: Parallels to influenza virus hemagglutinin and HIV-1 gp41
52. Recombinant vesicular stomatitis virus expression respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion
53. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells
54. Host cell proteases controlling virus pathogenicity
55. Activation of influenza A viruses by trypsin treatment
56. Crystal structure of human T cell luekemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins
57. Changes in conformation and charge paralleling proteolytic activation of Newcastle disease virus glycoproteins
58. Paramyxovirus fusion: A hypothesis for changes
59. Paramyxoviridae: The viruses and their replication
60. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion
61. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide
62. Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: Host cell activation of serum plasminogen
63. A trimeric structural domain of the HIV-1 transmembrane glycoprotein
64. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9 Å resolution
65. The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil
66. The free energy released during the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion
67. Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: Requirements for membrane fusion
68. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41
69. Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion
70. Activation of precursors to both glycoproteins of Newcastle disease virus by proteolytic cleavage
71. Membrane penetration of Sendal virus glycoproteins during the early stage of fusion with liposomes as determined by hydrophobic affinity labeling
72. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: Comparison of the individual contributions of the F and G glycoproteins to host immunity
73. Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and KEX2
74. Expression at the cell surface of biologically active fusion and hemagglutinin-neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA
75. Ability of the hydrophobic fusion-related external domain of a paramyxovirus F protein to act as a membrane anchor
76. Fusion protein of the paramyxovirus SV5: Destabilizing and stabilizing mutants of fusion activation
77. Role of gp41 glycosylation sites in the biological activity of human immunodeficiency virus type 1 envelope glycoprotein
78. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: An emerging similarity with functional domains of other viruses
79. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein
80. Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin
81. Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein
82. Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genes
83. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus
84. F protein-F protein interaction within the Sendai virus identified by native bonding or chemical cross-linking
85. Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion
86. Coiled coils in both intracellular vesicle and viral membrane fusion
87. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin
88. Atomic structure of a thermostable subdomain of HIV-1 gp41
89. Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge
90. Monoclonal antibodies to three structural proteins of Newcastle disease virus: Biological characterization with particular reference to the conformational change of envelope glycoproteins associated with proteolytic cleavage
91. Proteolytic cleavage of the fusion protein but not membrane fusion is required for measles virus-induced immunosuppression in vitro
92. Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles
93. The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil
94. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain
95. Atomic structure of the ectodomain from HIV-1 gp41
96. The ectodomain of HIV-1 env subunit gp41 forms a soluble, α-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide
97. Temperature dependence of fusion by Sendai virus
98. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition
99. Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection
100. Measles virus: Both the haemagglutinin and fusion glycoproteins and required for fusion
101. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution
102. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection
103. Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces
104. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling
105. Proper spacing between heptad repeat B and the transmembrane domain boundary of the paramyxovirus SF5 F protein is critical for biological activity